Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohammed Musa Najmuddin"'
Autor:
Razwana Khanam, Saba Batool, Mohammed Musa Najmuddin, Rana Usman, Kiran Kuriakose, Arooj Ahmed, Mohammad Ebad Ur Rehman, Zinath Roksana, Faiz Anwer
Publikováno v:
Blood. 140:12494-12495
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d3ee857aaf84434afcac11cc7ac6371
https://doi.org/10.1182/blood-2022-164871
https://doi.org/10.1182/blood-2022-164871
Autor:
Muhammad Ali Mirza, Abdul Jabbar Dar, Mobeen Zaka Haider, Tariq Iqtidar Sadiq Syed, Ali Jaan, Mohammed Musa Najmuddin, Karun Neupane, Tayyab Rehan, Syed Hashim Ali Inam, Saad Javed, Syed Maaz Abdullah, Hejab Fatima, Faiz Anwer, Muhammad Khawar Sana
Publikováno v:
Blood. 136:31-32
Introduction: Light chain amyloidosis (AL) is a plasma cell disorder associated with detrimental manifestations in multiple organ systems of the body. It is estimated that approximately 1275-3200 new cases occur in the United States annually. Proteas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d57ce3647168356caba30b4f9092fc
https://doi.org/10.1182/blood-2020-143106
https://doi.org/10.1182/blood-2020-143106
Autor:
Mobeen Zaka Haider, Saad Javed, Muhammad Khawar Sana, Tariq Iqtidar Sadiq Syed, Syed Hashim Ali Inam, Syed Maaz Abdullah, Muhammad Tayyeb, Mohammed Musa Najmuddin, Abdul Jabbar Dar, Karun Neupane, Faiz Anwer, Hejab Fatima, Muhammad Ali Mirza
Publikováno v:
Blood. 136:6-7
Introduction: Despite multiple treatment options, multiple myeloma (MM) remains an incurable disease. Chimeric antigen receptor T-cell (CAR T) therapy, a form of adoptive immunotherapy, has shown favorable outcomes in the treatment of hematological m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a525e96f0c55ac75c9753e7d1396d6ac
https://doi.org/10.1182/blood-2020-143045
https://doi.org/10.1182/blood-2020-143045